{"organizations": [], "uuid": "a62cd6ed3fbc746e2e5dd2fbd33524091ad0f238", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-veru-to-present-at-2018-genitourin/brief-veru-to-present-at-2018-genitourinary-cancers-symposium-idUSFWN1PW0O4", "country": "US", "domain_rank": 408, "title": "BRIEF-Veru to Present At 2018 Genitourinary Cancers Symposium", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-06T15:36:00.000+02:00", "replies_count": 0, "uuid": "a62cd6ed3fbc746e2e5dd2fbd33524091ad0f238"}, "author": "", "url": "https://www.reuters.com/article/brief-veru-to-present-at-2018-genitourin/brief-veru-to-present-at-2018-genitourinary-cancers-symposium-idUSFWN1PW0O4", "ord_in_thread": 0, "title": "BRIEF-Veru to Present At 2018 Genitourinary Cancers Symposium", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "veru inc", "sentiment": "none"}, {"name": "reuters) - veru inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Veru Inc:\n* VERU ANNOUNCES PRESENTATION OF DATA DEMONSTRATING EFFICACY OF VERU-111 IN A TAXANE RESISTANT HUMAN PROSTATE CANCER MODEL AT THE 2018 GENITOURINARY CANCERS SYMPOSIUM\n* VERU INC - ‍IN EARLY TOXICITY STUDIES, VERU-111 WAS WELL TOLERATED​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-06T15:36:00.000+02:00", "crawled": "2018-02-06T15:47:23.008+02:00", "highlightTitle": ""}